logo

For the Inventor, By the Inventor

Taipei, Taiwan

Min-Liang Kuo

This inventor holds 7 USPTO granted patents and 4 published patent applications. Top assignees: National Taiwan University, Microbio Co. Ltd., National Yang Ming Chiao Tung University. Active years: 2007-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Min-Liang Kuo. Retrieved from https://idiyas.com/inventor/min-liang-kuo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 28.6

Average Co-Inventor Count = 2.5

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Chiu, TW (2007)
  • Taipei, TW (2007 - 2021)

Company Filing History:

goldMedal5 out of 1,391 
 
National Taiwan University
 patents
silverMedal1 out of 8 
 
Microbio Co. Ltd.
 patents
bronzeMedal1 out of 1,244 
 
National Yang Ming Chiao Tung University
 patents
4. 1 out of 834,453 
Other
 patents
where one patent can have more than one assignee

Years Active: 2007-2021

Loading Chart...
7 patents (USPTO):Explore Patents
1. 11179425 - Method of activating tumor-infiltrating lymphocytes (TILs) (2021-11-23),
2. 8871721 - Methods for inhibiting peritoneal dissemination of cancer cells (2014-10-28),
3. 8383662 - Bicyclic heteroaryl compounds (2013-02-26),
4. 7825261 - Indazole compounds (2010-11-02),
5. 7618772 - Methods and compositions for diagnosing and suppressing metastasis thereof (2009-11-17),
6. 7214480 - Methods and compositions for diagnosing and suppressing metastasis thereof (2007-05-08),
7. 7202218 - Oligopeptide antagonist of interleukin-6 (2007-04-10),

Title: Min-Liang Kuo: Innovator in Cancer Treatment

Introduction

Min-Liang Kuo is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. With a total of 7 patents, Kuo's work focuses on enhancing the effectiveness of cancer therapies.

Latest Patents

Among his latest patents, Kuo has developed a method for activating tumor-infiltrating lymphocytes (TILs). This invention relates to a method for activating TILs in a subject in need, particularly by administering a fermented composition generated via fermentation of symbiotic microbiota in a medium. Another notable patent involves methods for inhibiting peritoneal dissemination of cancer cells. This pharmaceutical composition includes an effective dose of connective tissue growth factor (CTGF) and a pharmaceutically acceptable carrier.

Career Highlights

Kuo has worked at National Taiwan University, where he has contributed to various research initiatives. His work has been instrumental in advancing cancer treatment methodologies and improving patient outcomes.

Collaborations

Some of his notable coworkers include Cheng-Chi Chang and Chung-Ming Sun, who have collaborated with him on various projects.

Conclusion

Min-Liang Kuo's innovative approaches to cancer treatment through his patents highlight his dedication to improving healthcare. His contributions continue to influence the field and offer hope for better therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…